Treatment of ulcerative colitis by combined therapy of retention enema and per-colonoscopic spraying with zhikang capsule compound liquid.
- Author:
Jie ZHANG
1
;
Yu-feng ZENG
;
Bin-qiong XIAO
;
Juan WANG
;
Aihua ZHAO
Author Information
- Publication Type:Journal Article
- MeSH: Administration, Rectal; Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; drug therapy; pathology; Colonoscopy; Dexamethasone; administration & dosage; Drug Therapy, Combination; Drugs, Chinese Herbal; administration & dosage; Female; Gentamicins; administration & dosage; Humans; Male; Middle Aged; Phytotherapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2005;25(9):839-842
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the therapeutic efficacy of patients with ulcerative colitis (UC) treated by retention enema and per-colonoscopic spraying of Zhikang Compound Liquid (ZKCL).
METHODSEighty-six patients with UC were divided into two groups. The 52 patients in the treated group were treated for 4 courses of retention enema, the drug for enema used in the 1st course was ZKCL-A (consisted of normal saline, Zhikang capsule, gentamycin and dexamethasone) and smecta, in the 2nd course ZKCL-A alone, in the 3rd and 4th course, ZKCL-B (with the same contents of ZKCL-A but without dexamethasone), the enema was carried out once a day in the evening, 15 days as one course. Besides, local spraying of ZKCL-A and smecta were given once by colonoscopy before the 1st and 3rd course. The 34 patients in the control group were treated by salicylazosulfapyridine orally.
RESULTSIn the treated group, 32 patients got complete remitted, 15 were treated effectively, 5 ineffectively, the total effective rate being 90.38% while the corresponding number in the control group were 8, 14, 12, and 64.71%, respectively. Significant difference was seen when compared with the therapeutic effects of the two groups. CONCLUSION Good efficacy was got in treating patients with UC by retention enema and per-colonoscopic spraying with ZKCL.
